Documente Academic
Documente Profesional
Documente Cultură
Anecdotal evidence suggests that high fibre Epidemiological evidence suggests that a high intake of
supplementation of dietary intake may have health benefits dietary fibre is associated with numerous health benefits.1 To
in renal disease related to alterations in circulating levels of date, much of the research interest has focused on their role
short-chain fatty acids. The aim of the study was to examine in protection against colorectal cancer and inflammatory
the hypothesis that dietary manipulation may increase serum bowel disease. However, there is now evidence that altered
butyrate and thus have potential beneficial effects in renal systemic levels of short-chain fatty acids (SCFA), resultant
disease. We examined the effect of dietary supplementation from colonic bacterial fermentation of fibre, may also offer
with a gum arabic sample of standardized molecular health benefit beyond the gastrointestinal tract. Studies over
characteristics, Acacia(sen) SUPERGUMTM EM2 the last decade have linked dietary fibre intake and
(SUPERGUMTM), on systemic levels of butyrate in normal cardiovascular risk and also epithelial cell carcinogenesis in
human subjects. In an in vitro study, we also examined the numerous organs including the kidney. These health benefits
potential role of butyrate in modifying the generation of of high-fibre diets are thought to be specifically linked to the
the profibrotic cytokine transforming growth factor-beta generation of the SCFA butyrate, which displays a host of
(TGF-b1) by renal epithelial cells. Following 8 weeks of dietary biologically important effects in vitro, including modulation
supplementation with 25 g/day of SUPERGUMTM, there was a of cell proliferation, apoptosis, regulation of angiogenesis and
two-fold increase in serum butyrate (n ¼ 7, P ¼ 0.03). In vitro inflammation.2
work demonstrated that exposure of renal epithelial cells to Gum arabic is a tree gum exudate, which has been an
elevated concentrations of butyrate suppressed both basal important food ‘additive’ since ancient times. Supplementa-
and stimulated TGF-b1 synthesis. The action of butyrate was tion of the diet with gum arabic has been shown to increase
mediated by suppression of the extracellular signal-regulated faecal nitrogen excretion and lower serum urea nitrogen
kinase/mitogen-activated protein kinase signalling pathway. concentration in patients with chronic renal failure.3 This
In addition, butyrate exposures reduced the response of is dependent on an increase in bacterial growth and activity
renal epithelial cells to TGF-b1 as assessed by luciferase in the gut. Colonic bacteria produce ureases that hydrolyse
activity of a TGF-b-responsive reporter construct. Attenuation urea to ammonia and CO2. The resultant ammonia can
of TGF-b1 signalling was associated with reduced then be incorporated into bacterial proteins, which are
phosphorylation of Smad 3 and decreased trafficking of subsequently excreted in the bacterial mass fraction of the
TGF-b1 receptors into signalling, non-lipid raft-associated faeces. The net result is increased N excretion in the faeces.
membrane fractions. In conclusion, the data demonstrate More recent studies, in rat models of acute renal failure,4
that dietary supplementation with SUPERGUMTM increased suggest that gum arabic may also improve renal function
serum butyrate, which at least in vitro has beneficial effects independently of its action on faecal bacterial ammonia
on renal pro-fibrotic cytokine generation. metabolism.
Kidney International (2006) 69, 257–265. doi:10.1038/sj.ki.5000028 It is now clear that in renal disease, regardless of its
KEYWORDS: TGF-b; renal; butyrate; SUPERGUM aetiology, the prognosis best correlates with the degree of
renal interstitial fibrosis. As a result, interest has focused on
Correspondence: AO Phillips, Institute of Nephrology, School of Medicine,
the role of cells, such as the epithelial cells of the proximal
Cardiff University, Heath Park, Cardiff CF14 4XN, UK. tubule, in the initiation of the fibrotic response. There is now
E-mail: PhillipsAO@cf.ac.uk overwhelming evidence that the pro-fibrotic cytokine trans-
Received 15 June 2005; revised 15 August 2005; accepted 15 September forming growth factor-beta (TGF-b1) is a key mediator of
2005 progressive renal injury. Much of our research work has
Butyrate (mol/l)
0.8
between ingestion of gum arabic and systemic levels of SCFA
in human subjects, and examined the effects of the SCFA 0.6
butyrate and propionate on the generation of, and response
to, the pro-fibrotic cytokine TGF-b1 in vitro in proximal 0.4
TGF-1 (ng/ml)
TGF-1 (ng/ml)
100 300
1.6370.24 mmol/l; study end: 1.5970.25 mmol/l, n ¼ 10, * 200 *
*
P40.05) during the course of the fibre supplementation 200
50
period (Figure 1b). 100
100
Butyrate decreases basal TGF-b1 generation. Addition of
butyrate led to a dose-dependent reduction in the generation 0
0 0.5 1 5 10
0
0 0.5 1 5 10
0
0 0.5 1 5 10
of TGF-b1 (Figure 2). A significant reduction in this Concentration (mM) Concentration (mM) Concentration (mM)
‘unstimulated’ constitutive generation was seen at concentra- Figure 2 | Butyrate suppresses basalTGF-b1 production by
tions of butyrate of 5 mM and above. In contrast, addition of tubular epithelial cells. Increasing doses of butyrate were added to
propionate over the concentration range 0–10 mM did not confluent monolayers of serum-deprived HK2 cells under serum-free
conditions. Cell culture supernatant samples were collected after
influence TGF-b1 synthesis at any of the time points studied (a) 24, (b) 48, and (c) 72 h and TGF-b1 was quantified by ELISA. Data
(Figure 3). represent mean7s.d.; n ¼ 6. *Po0.05 compared to serum-free
The doses of the SCFA used were non-toxic. Over the medium in the absence of butyrate.
concentration range used, there were no alterations in
fluorescence readings following addition of butyrate or protein (MAP) kinase pathway is involved in the stimulation
propionate, as assessed by alamarBlue assay (data not of promoter activity, whereas the extracellular signal-
shown). regulated kinase (ERK)/MAP kinase pathway may regulate
Our previous studies have demonstrated independent post-transcriptional events.8 The potential involvement of
mechanism regulating transcription and translation of TGF- these two signalling pathways in TGF-b1 generation under
b1.6,7 Furthermore, signalling via the p38 mitogen-activated basal conditions was assessed by determining the impact of
inhibition of these pathways on TGF-b1 concentration. assessed by the alamarBlue assay (data not shown). The
SB203580 and PD98059 (Calbiochem, Nottingham, UK) hypothesis that butyrate may mediate its effect by inhibition
are cell-permeable inhibitors of p38 kinase and MAP kinase of ERK/MAP kinase was also supported by immunoblot
kinase (MEK), respectively. Addition of the MEK inhibitor analysis demonstrating both dose-(Figure 4c) and time-
PD98059 (Figure 4a), but not the p38 MAP kinase inhibitor dependent (Figure 4d) suppression of ERK phosphorylation
(Figure 4b), mimicked the effect of butyrate and led to a in unstimulated monolayers of HK-2 cells.
significant reduction in TGF-b1 concentration in the culture Glucose-stimulated TGF-b1 synthesis is inhibited by butyrate.
supernatant (Figure 5). Neither compound over the con- We have previously demonstrated, in our in vitro model of
centration ranges used led to any toxic effect on cells as the diabetic state, that exposure of HK-2 cells to elevated
concentrations of D-glucose for 7 days stimulates de novo
TGF-b1 synthesis.8 Having determined the effect of SCFA on
a 24 h b 48 h c 72 h basal/constitutive TGF-b1 synthesis, we next sought to
150 400
500
examine their effect on glucose-stimulated TGF-b1 synthesis.
300 Addition of 25 mM D-glucose led to a significant increase
TGF-1 (ng/ml)
TGF-1 (ng/ml)
400
TGF-1 (ng/ml)
100
200
300 in the concentration of TGF-b1 in the culture supernatant, as
200
previously demonstrated.8 Glucose-stimulated increase in
50
100 TGF-b1 was significantly attenuated when cells were cultured
100
in the presence of 25 mM D-glucose together with butyrate
0 0 0
0 0.5 1 5 10 0 0.5 1 5 10 0 0.5 1 5 10
(Figure 5a). Propionate in contrast did not influence glucose-
Concentration (mM) Concentration (mM) Concentration (mM) stimulated TGF-b1. To confirm that reduced TGF-b1
Figure 3 | Propionate has no effect on basal TGF-b1production concentration following addition of butyrate was the result
by tubular epithelial cells. Increasing doses of propionate were of decreased synthesis, we assessed de novo synthesis of TGF-
added to confluent monolayers of serum-deprived HK2 cells under b1 by detection of radioactive amino-acid incorporation into
serum-free conditions. Cell culture supernatant samples were
collected after (a) 24, (b) 48, and (c) 72 h and TGF-b1 was quantified
TGF-b1.8 Consistent with the enzyme-linked immuno-
by ELISA. Data represent mean7s.d.; n ¼ 6. P40.05 for all samples sorbent assay (ELISA) data, 25 mM D-glucose-stimulated
compared to serum-free medium in the absence of propionate. synthesis of radiolabelled TGF-b1 was also reduced in the
a 125
b
100
100
75
TGF-1 (ng/ml)
TGF-1 (ng/ml)
75 ∗
50
50
25
25
0 0
PD98059 0 0.8 8.0 80 M SB203580 0 30 300 3000 ng/ml
c d
Phospho-ERK
0 0.1 1 mM 0 0.1 1 mM
5 10 15 30 min
Butyrate Propionate Butyrate – + – + – + – +
Total ERK
Figure 4 | Butyrate-mediated suppression of TGF-b1 is associated with suppression of ERK activation. Increasing doses of either (a) the
MEK inhibitor PD98059 or (b) p38 MAP kinase inhibitor SB203580 were added to confluent monolayers of HK-2 cells under serum-free
conditions for 24 h. Subsequently, cell culture supernatant samples were collected for analysis of TGF-b1 concentration by ELISA. Data
represent mean7s.d.; n ¼ 3. *Po0.05 compared to serum-free medium alone in the absence of inhibitor. In parallel experiments, the effect of
butyrate on ERK activation was examined by immunoblot analysis using antibodies to either dually phosphorylated active form of MAPK (p44/
ERK1 and p42/ERK2) or total MAPK. (c) To determine the dose-dependent effect of SCFA, butyrate or propionate at the concentrations shown
was added to confluent HK2 cell monolayers in the absence of serum for 30 min. (d) Time-dependent effects of butyrate were examined by
addition of 1 mM butyrate to confluent monolayers of HK2 cells for up to 30 min. Cell lysis and immunoblot analysis were carried out as detailed
in Materials and Methods.
a 1500 a b
1500
1500
*
TGF-1 (ng/ml)
TGF-1 (ng/ml)
1000 **
1000
1000 *
TGF-1 (ng/ml)
500 500
0 0
500
D-glucose 5 25 25 25 25 mM D-glucose 5 25 25 25 25 mM
PD98059 0 0 0.8 8.0 80 M SB203580 0 0 30 300 3000 ng/ml
c d
0 pERK
0 0.1 1
Butyrate/propionate concentration (mM)
Total ERK
presence of butyrate, but was unaffected by the addition of D-glucose in the presence of butyrate compared with that
propionate (Figure 5b). seen in the control cell (Figure 6d).
The involvement of the p38 and MAP kinase pathways in Butyrate suppresses TGF-b1-dependent signalling. Activa-
25 mM D-glucose-stimulated TGF-b1 synthesis was deter- tion of the Smad signalling pathway was examined using the
mined by addition of glucose in the presence of either (SBE)4-Lux reporter, which contains four repeats of the
SB203580 or PD98059. Stimulation of cells with 25 mM CAGACA sequence identified as a SMAD-binding element.
D-glucose in the presence of PD98059 led to a dose-dependent Addition of TGF-b1 led to a significant increase in luciferase
decrease in glucose-stimulated TGF-b1 concentration (Figure activity (Figure 7). Stimulation of HK-2 cells transfected with
6a). In contrast, inhibition of the p38 MAP kinase pathway the reporter construct with TGF-b1 in the presence of
did not affect glucose-stimulated TGF-b1 generation (Figure butyrate blunted TGF-b1-dependent activation of Smad
6b). D-glucose (25 mM)-stimulated activation of the ERK/ signalling, as luciferase activity was significantly lower in
MAP kinase pathway was examined by immunoblot analysis the presence of either 1 or 10 mM butyrate (Figure 7a).
of ERK phosphorylation. A time-dependent increase in Stimulation with TGF-b1 in the presence of propionate in
p-ERK was demonstrated 10 min after addition of 25 mM contrast did not affect TGF-b1-dependent activation of the
D-glucose, with maximal stimulation seen at 15 min (Figure 6c). reporter construct (Figure 7b).
Addition of 25 mM D-glucose had no effect on the expression of Activation of the Smad signalling pathway was also
total ERK. The effect of butyrate on glucose-stimulated ERK examined by immnuoblot analysis of phosphorylated Smad
activation was examined by stimulation of HK-2 cells with 2/3 (Figure 8). Addition of TGF-b1 increased Smad phospho-
25 mM D-glucose in the presence of 1 mM butyrate for 15 min. rylation. As with reporter construct activity, TGF-b1-
These experiments demonstrated abrogation of 25 mM dependent phosphorylation of Smad was blunted in the
D-glucose activation of ERK such that there was no difference presence of butyrate in a dose-dependent manner, while
in ERK phosphorylation following addition of 25 mM propionate did not influence Smad phosphorylation.
a P = 0.003 a
P = 0.012
pSMAD
2
Fold increase in luciferase (CAGA) activity
b Raft Non-raft
over control
1 Fraction 2 3 4 5 6 7 8 9 10 11 12
Control
0.5
TGF-
0 TGF-+
0 1 10 butyrate
Butyrate (mM)
c 100
b 2
Fold increase in luciferase (CAGA) activity
Receptor distribution
(percentage of total)
75
1.5 Raft
50
Non-raft
over control
25
1
0
Control TGF- TGF-+
0.5 butyrate
Studies dating back over 20 years have shown that locust beneficial effects in renal disease, we have examined the in
bean gum, a non-digestible polymer of mannose and vitro effects of butyrate on the generation of the pro-fibrotic
galactose derived from the seeds of the Ceratonia siliqua cytokine TGF-b1 and also the responsiveness of cells to the
tree, was an efficient sorbent, which bound to many of the effects of TGF-b1 in vitro. There is clear evidence that this
potential toxic substances found in patients with chronic cytokine is involved in the final common pathway of renal
renal failure.14 Subsequently, in a study of only two patients, fibrosis in all renal diseases, and antagonism of its action has
it was suggested that dietary supplementation with locust been proposed as a potential therapeutic goal.23–27 There is a
bean gum improved blood pressure control and reduced close correlation between rate of progression of renal disease
serum creatinine.15 These observations, which have not been and the degree of interstitial fibrosis. Furthermore, it is well
investigated further, if confirmed would suggest a mechanism established that the epithelial cells of the proximal tubule
other than that related to its ‘sorbent’ properties by which contribute to this fibrotic process, both by generation of
locust bean gum may influence progressive renal disease. In cytokines such as TGF-b1 6,7,28 and by a process of
addition, a single study using dietary supplementation with epithelial—mesenchymal transdifferentiation under the in-
the hemicellulosic ispaghula husk also suggested a beneficial fluence of TGF-b1, through which contribute to the
effect on renal function beyond increased faecal bacterial population of renal interstitial fibroblasts, which mediate
loss.16 deposition of interstitial extracellular matrix in disease.29 We
Our interest in the potential health benefit of gum arabic have therefore focused on the modulation effect of butyrate
stems from two studies demonstrating that supplementation on TGF-b1 in this renal epithelial cell. The results clearly
of the diet with gum arabic increases faecal nitrogen excretion demonstrate that at non-toxic doses, exposure to elevated
and lower serum urea nitrogen concentration in patients with concentrations of butyrate prevents TGF-b1 generation.
chronic renal failure,3 and work in rat models of acute renal More specifically, the data demonstrate that both basal/
failure, which suggests that gum arabic may improve renal constitutive TGF-b1 synthesis and glucose-stimulated gen-
function independently of its action on faecal bacterial eration of TGF-b1 are suppressed. Previously, we have
ammonia metabolism.4 demonstrated the involvement of both the p38 MAP kinase
The aim of this study was to examine the hypothesis that and ERK/MAP kinase pathways in the regulation of
dietary supplementation with gum arabic in humans will transcriptional and translational regulation of TGF-b1,
increase systemic levels of the SCFA, which in turn may have respectively.8 In this study, the data suggest that butyrate-
actions at the cellular level and a beneficial effect on the mediated inhibition of TGF-b1 synthesis is related to the
development and progression of renal fibrosis. specific inhibition of the ERK/MAP kinase pathway. This
The first significant observation is the demonstration of coupled to our previous work would suggest that butyrate
elevated serum butyrate levels in human subjects who may therefore specifically modulate the synthesis of TGF-b1
received 25 g/day of specific gum arabic (Acacia(sen) SUPER- translation. It is of note that the effects of butyrate in the in
TM
GUM ). Completion of the full 10-week protocol by all of vitro situation were seen at concentrations far in excess of the
the subjects confirms the tolerability of such an approach. circulating serum levels seen in the in vivo feeding study. How
Butyrate is considered a preferred fuel for colonocytes and is circulating levels relate to tissue levels, and in particular to
believed to be selectively extracted by them,17 resulting in levels in the kidney and more specifically in the environment
relatively low butyrate concentrations in the portal blood.18 of the proximal tubular epithelial cell, remains a matter for
Furthermore, as the vast majority of butyrate is likely to be speculation. The concentrations used, however, are in line
extracted by the liver,19 alterations in systemic butyrate are with previous studies in which the effects of butyrate on renal
likely to be at low levels.18 Our data, however, are consistent cell function have been studied.30,31 These in vitro observa-
with other studies, which suggest that increased colonic tions therefore merit further clinical studies to validate their
butyrate production in human subjects can be detected by potential importance.
increased serum butyrate.20 It is interesting to note that in TGF-b1 receptors internalize into both caveolin- and
contrast to the increase in butyrate levels, we were unable to EEA-1-positive vesicles and reside in both lipid raft and non-
demonstrate any alteration in serum propionate in the raft membrane domains.11 Clathrin-dependent internaliza-
subjects given the test material. We postulate that this is tion into the EEA-1-positive endosome promotes TGF-b1
related to the fact that the majority of colonic propionate is signalling. In contrast, the lipid raft-caveolar internalization
taken up by the liver19 where it inhibits the incorporation of pathway contains Smad7-bound receptor and is required for
acetate into lipids21 and can be utilized as a gluconeogenic receptor turnover. Altered receptor trafficking between these
substrate.22 two membrane receptor pools may influence TGF-b1
Many studies have demonstrated that the SCFA butyrate signalling in a stimulus-specific manner resulting in either
displays a host of biologically important effects in vitro, enhancement10 or attenuation9 of TGF-b1 signalling. In this
including modulation of cell proliferation, apoptosis, regu- study, we have demonstrated attenuation of TGF-b1 signal-
lation of angiogenesis and inflammation.2 ling in the presence of butyrate, using a TGF-b1-responsive
In order to provide a mechanistic basis to the hypothesis promoter construct, and also phosphorylation of Smad
that gum arabic supplementation of the diet may have proteins as markers of TGF-b1 response. Furthermore,
attenuation of TGF-b1 signalling was associated with been generated in a renal epithelial cell line, given this wider
inhibition of trafficking of TGF-b RI in the cell membrane. role of TGF-b in health and disease, the general applicability
In conclusion, the data support the hypothesis that dietary of our findings to other organ systems may have important
TM
supplementation with Acacia(sen) SUPERGUM (gum ara- health implications.
bic), by increasing systemic levels of butyrate, may have a
potential beneficial effect in renal disease by suppression of MATERIALS AND METHODS
TGF-b1 activity. Confirmation that the alterations in Effect of gum arabic on SCFA in vivo
systemic butyrate levels documented in this study may have Test material. The test gum Acacia(sen) SUPERGUMTMEM2
comparable in vivo effects to those demonstrated in this cell (SUPERGUMTM) has precisely structured molecular dimensions
culture system therefore warrants further in vivo investiga- and chemical composition as shown in Tables 1–6.
tion. TGF-b1 is a multifunctional cytokine, which controls a Protocol for dietary supplementation. Healthy volunteers
(n ¼ 10) each had their normal diet supplemented with 25 g
plethora of biological responses, and alterations in its
SUPERGUMTM daily. The daily amount of SUPERGUMTM was
signalling pathway are associated with a range of human provided in a dried form in individual sealed foil pouches. The
diseases. It is important in development and normal wound SUPERGUMTM was reconstituted in 250 ml of water and shaken to
healing through its effects on cell proliferation, migration, ensure adequate mixing. The volunteers then added flavouring to
differentiation and apoptosis.32 In addition, it is a critical taste and consumed the SUPERGUMTM mixture.
regulator of the normal inflammatory response, as illustrated Compliance was assessed by counting the foil pouches returned
by the death of TGF-b1/ mice of a multifocal inflamma- to the department. Volunteers were also questioned about ill effects
tory syndrome soon after weaning.33 It has growth inhibitory from the fibre supplementation.
effects, which explains its role as a tumor suppressor early in Quantitation of butyrate and propionate. Serum for mea-
the course of disease. Its expression by tumor cells, however, surement of SCFA was obtained before and 10 weeks after
also contributes to cancer progression and metastasis at later commencing dietary supplementation with SUPERGUMTM. Volun-
stages of disease.34,35 TGF-b1 also plays a central role in the teers attended after an overnight fast, and a 12 ml blood sample was
obtained and placed into two 6 ml tubes containing serum clot
pathological process of fibrosis, which may lead to organ
activator (Vacuette, Greiner labortechnik, Kremsmunter, Austria).
failure.36,37 Although the data presented in this paper have Once clotted, the serum was immediately separated by centrifuga-
tion for 7 min at 2000 r.p.m. and 41C. Aliquots of serum were stored
at 701C and batched for measurement of SCFA.
Table 1 | Percentage loss on drying and specific rotation Serum butyrate and propionate were measured in quadruplicate
of the matured gum arabic by gas chromatography as previously described.38 Statistical
significance was assessed by standard non-parametric tests (Wilcox-
% loss on Specific rotation on) using SPSS 11 statistical computer package.
Sample name drying (%wt) (deg/dm cm3/g)
Matured gum arabic (SUPERGUMTM EM2) 6.25 31 Table 5 | Trace metal analysis (ICP) of the matured gum arabic
(lg/g) Supergum EM2
In vitro effects of SCFA the cells in Reporter Lysis Buffer (Promega, WI, USA), the luciferase
Cell culture. HK-2 cells (human renal proximal tubular epithelial content was quantified by glow-type luminescence assay (Bright-
cells immortalized by transduction with human papilloma virus (HPV Glo, Promega), and b-galactosidase activity determined by a
16 E6/E7 genes39) were cultured as previously described.40–43 commercial assay (Promega). Luciferase activity was normalized to
Toxicity/cell viability. Cell viability was assessed by the ability b-galactosidase activity.
of monolayers to reduce the dye alamarBlue. At the end of each Detergent-free purification of the lipid raft-rich membrane
experimental period/manipulation, alamarBlue reagent was added fraction. HK-2 cells were grown to near confluence in 100 mm
to make up a final volume of 10% of the culture medium. The cells dishes. After two washes with ice-cold phosphate-buffered saline,
were returned to the incubator for 1 h, after which 100 ml aliquots of two confluent dishes were scraped into 2 ml of 500 mM sodium
medium were quantified for alamarBlue fluorescence using a carbonate, pH 11.0. Homogenization was carried out by three 20 s
Fluostar Optima Fluorescence Meter of excitation wavelength bursts of ultrasonic disintegrator (Soniprep 150, Fisher Scientific) to
544 nm and detection wavelength 590 nm. disrupt cellular membranes as previously described.46 The homo-
Quantitation of TGF-b1. Total TGF-b1 in the cell culture genates were adjusted to 45% sucrose by addition of 2 ml of 90%
supernatant was measured by specific ELISA (R&D Systems, sucrose prepared in MBS (2-(N-morpholino) ethanesulphonic acid-
Abingdon, UK) of cell culture supernatant samples collected from buffered saline;, 25 mM 2-(N-morpholino) ethanesulfonic acid, pH
growth-arrested HK-2 cells, stimulated under serum-free condi- 6.5, 0.15 M NaCl) and placed at the bottom of an ultracentrifuge
tions. Active TGF-b1 was measured directly and latent TGF-b1 can tube. A discontinuous sucrose gradient (4 ml of 35% sucrose, 4 ml of
be measured indirectly following acid activation of samples. 5% sucrose, both prepared in MBS) was formed above and
Assessment of de novo TGF-b1 synthesis. De novo TGF-b1 centrifuged at 39 000 r.p.m. for 16–20 h, in an SW40 TI rotor
synthesis was examined by detection of radioactive amino-acid (Beckman Instruments, Palo Alto, CA, USA). A light-scattering
incorporation into newly synthesized protein by metabolic labelling band was observed at the 3–35% sucrose interface. A total of 12 1-ml
and detection by TGF-b1 immunoprecipitation and autoradiogra- fractions were collected from the top of the tubes, and a portion of
phy as previously described.8 each fraction was analysed by SDS-PAGE (10% gel) and immuno-
blot analysis for TGF-b RI, which was quantified by densitometry
Western blot analysis. Equal numbers of cells were lysed by
(Chemi Doc, Bio-Rad, Hemel Hempstead Herts, UK). Data are
addition of sodium dodecyl sulphate (SDS) sample buffer, and
expressed as a percentage of the total TGF-b:receptor complex for
100 ml of the resultant lysates was boiled for 5 min at 951C before
that experiment in each fraction.
loading onto SDS-polyacrylamide electrophoresis (SDS-PAGE) gel
(5–15%). Electrophoresis was carried out under reducing condi-
tions.44 Separated proteins were transferred to a nitrocellulose Statistical analysis
membrane (Amersham, Little Chalfont, UK). Following a blocking Statistical analysis was performed using the unpaired Student’s
step, membranes were incubated with the appropriate primary t-test, with a value of Po0.05 considered to represent a significant
antibody in Tris-buffered saline containing 0.1% Tween 20 difference. The data are presented as means7s.d. of n experiments
(phosphate-buffered saline-Tween) overnight at 41C. Primary as indicated in the figure legends. For each individual experiment,
antibodies were as follows: the mean of duplicate determinations was calculated.
8. Fraser DJ, Brunskill NJ, Phillips AO. Long-term exposure of proximal 29. Zeisberg M, Hanai J, Sugimoto H et al. BMP-7 counteracts
tubular epithelial cells to glucose induces TGF-b1 synthesis via an TGF-beta1-induced epithelial-to-mesenchymal transition and reverses
autocrine PDGF loop. Am J Pathol 2003; 163: 2565–2574. chronic renal injury. Nat Med 2003; 9: 964–968.
9. Ito T, Williams JD, Fraser DJ et al. Hyaluronan regulates TGF-b1 receptor 30. Hara I, Miyake H, Hara S et al. Sodium butyrate induces apoptosis in
compartmentalisation. J Biol Chem 2004; 279: 25326–25332. human renal cell carcinoma cells and synergistically enhances their
10. Zhang XL, Topley N, Ito T et al. IL-6 regulation of TGF-b receptor sensitivity to anti-Fas-mediated cytotoxicity. Int J Oncol 2000; 17:
compartmentalisation and turnover enhances TGF-b1 signalling. J Biol 1213–1218.
Chem 2005; 280: 12239–12245. 31. Moyer BD, Loffing-Cueni D, Loffing J et al. Butyrate increases apical
11. Di Guglielmo GM, Le Roy C, Goodfellow AF et al. Distinct endocytic membrane CFTR but reduces chloride secretion in MDCK cells.
pathways regulate TGF-beta receptor signalling and turnover. Nat Cell Am J Physiol 1999; 277: F271–F276.
Biol 2003; 5: 410–421. 32. Roberts AB, Flanders KC, Kondaiah P et al. Transforming growth factor b:
12. Burkitt DP, Trowell HC. Nutritional intake, adiposity, and diabetes. biochemistry and roles in embryogenesis, tissue repair and remodeling,
BMJ 1979; 1: 1083–1084. and carcinogenesis. Rec Progr Horm Res 1988; 44: 157–197.
13. Burkitt DP, Trowell HC. Dietary fibre and western diseases. Irish Med J 33. Kulkarni AB, Karlsson S. Transforming growth factor beta1 knockout mice:
1977; 70: 272–277. a mutation in one cytokine gene causes a dramatic inflammatory disease.
14. Yatzidis H. Preliminary studies with locust bean gum, a new sorbent with Am J Pathol 1993; 143: 3–9.
great potential. Kidney Int 1977; 12: 152A. 34. Tang B, Vu M, Booker T et al. TGF-beta switches from tumor suppressor to
15. Yatzidis H, Koutsicos D, Digenis P. Newer oral sorbents in uremia. Clin prometastatic factor in a model of breast cancer progression. J Clin Invest
Nephrol 1979; 11: 105–106. 2003; 112: 1116–1124.
16. Rampton DS, Cohen SL, Crammond VB et al. Treatment of chronic renal 35. Tang B, Böttinger EP, Jakowlew SB et al. Transforming growth factor b1 is
failure with dietary fiber. Clin Nephrol 1984; 21: 159–163. a new form of tumor suppressor with true haploid insufficiency. Nat Med
17. Roediger WE. Role of anaerobic bacteria in the metabolic welfare of the 1998; 4: 802–807.
colonic mucosa in man. Gut 1980; 21: 793–798. 36. Border WA, Ruoslahti E. Transforming growth factor b in disease: the dark
18. Cummings JH, Pomare EW, Branch WJ et al. Short chain fatty acids in side of tissue repair. J Clin Investig 1992; 90: 1–7.
human large intestine, portal, hepatic and venous blood. Gut 1987; 28: 37. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis.
1221–1227. N Engl J Med 1994; 331: 1286–1292.
19. Remesy C, Demigne C, Chartier F. Origin and utilization of volatile fatty 38. Wolever TM, Fernandes J, Rao AV. Serum acetate:propionate ratio is
acids in the rat. Reprod Nutr Dev 1980; 20: 1339–1349. related to serum cholesterol in men but not women. J Nutr 1996; 126:
20. Wolever TM, Chiasson JL. Acarbose raises serum butyrate in human 2790–2797.
subjects with impaired glucose tolerance. Br J Nutr 2000; 84: 57–61. 39. Ryan MJ, Johnson G, Kirk J et al. HK-2: An immortalized proximal tubule
21. Wolever TM, Spadafora PJ, Cunnane SC et al. Propionate inhibits epithelial cell line from normal adult human kidney. Kidney Int 1994; 45:
incorporation of colonic [1,2-13C]acetate into plasma lipids in humans. 48–57.
Am J Clin Nutr 1995; 61: 1241–1247. 40. Fraser DJ, Wakefield L, Phillips AO. Independent regulation of
22. Wolever TM, Spadafora P, Eshuis H. Interaction between colonic acetate transforming growth factor-\{beta\}1 transcription and translati.
and propionate in humans. Am J Clin Nutr 1991; 53: 681–687. Am J Pathol 2002; 161: 1039–1049.
23. Akagi Y, Isaka Y, Arai M et al. Inhibition of TGF-b1 expression by antisense 41. Janssen U, Thomas G, Glant T et al. Regulation of inter-alpha-trypsin
oligonucleotides suppressed extracellular matrix accumulation in inhibitor (IaI) and tumour necrosis factor-stimulated gene 6 (TSG-6)
experimental glomerulonephritis. Kidney Int 1996; 50: 148–155. expression in human renal proximal tubular epithelial cells. Kidney Int
24. Peters H, Border WA, Noble NA. Targeting TGF-b1 overexpression in renal 2001; 60: 126–136.
disease: maximizing the antifibrotic action of angiotenin II blockade. 42. Jones SG, Jones S, Phillips AO. Regulation of renal proximal tubular
Kidney Int 1998; 54: 1570–1580. epithelial cell hyaluronan generation: implications for diabetic
25. Cheol DC, Hoffman BB, Hong SW et al. Therapy with antisense TGF-b1 nephropathy. Kidney Int 2001; 59: 1739–1749.
oligodeoxynucleotides reduces kidney weight and matrix mRNAs in 43. Morrisey K, Evans RA, Wakefield L et al. Translational regulation of renal
diabetic mice. Am J Physiol 2000; 278: F628–F634. proximal tubular epithelial cell transforming growth factorb1 generation
26. Isaka Y, Tsujie M, Ando Y et al. Transforming growth factor b1 antisense by insulin. Am J Pathol 2001; 159: 1905–1915.
oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral 44. Laemmli UK. Cleavage of structural proteins during the assembly the
obstruction. Kidney Int 2000; 58: 1885–1892. head of bacteriophage T4. Nature 1970; 227: 680–685.
27. Isalm M, Burke JF, McGowan TA et al. Effect of transfroming growth 45. Piek E, Moustakas A, Kurisaki A et al. TGF-(beta) type I receptor/ALK-5 and
factor-b antibodies in cyclosporine-induced renal dysfunction. Kidney Int Smad proteins mediate epithelial to mesenchymal transdifferentiation in
2001; 59: 498–506. NMuMG breast epithelial cells. J Cell Sci 1999; 112: 4557–4568.
28. Phillips AO, Topley N, Morrisey K et al. Basic fibroblast growth factor 46. Song KS, Li S, Okamoto T et al. Co-purification and direct interaction
stimulates the release of pre-formed TGF-b1 from human proximal of Ras with caveolin, an integral membrane protein of caveolae
tubular cells in the absence of de-novo gene transcription or mRNA microdomains. Detergent-free purification of caveolae microdomains.
translation. Lab Invest 1997; 76: 591–600. J Biol Chem 1996; 271: 9690–9697.